Hepatic cytochrome P450 regulation in disease states

Current Drug Metabolism

Volumn 2, Issue 2, 2001, Pages 165-183

  Cheng, P Y ^a   Morgan, E T ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOXAN; CAFFEINE; CHLORZOXAZONE; CYTOCHROME; CYTOCHROME P450; CYTOCHROME P450 1A2; CYTOCHROME P450 2A1; CYTOCHROME P450 2A2; CYTOCHROME P450 2B1; CYTOCHROME P450 2C11; CYTOCHROME P450 2C12; CYTOCHROME P450 2C13; CYTOCHROME P450 2C6; CYTOCHROME P450 2C7; CYTOCHROME P450 2E1; CYTOCHROME P450 3A; CYTOCHROME P450 4A; CYTOKINE; GROWTH HORMONE; INSULIN; INTERFERON; LIVER ENZYME; MESSENGER RNA; QUININE; STREPTOZOCIN; TESTOSTERONE; THEOPHYLLINE; THYROXINE; TOLBUTAMIDE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ALLOXAN DIABETES MELLITUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DIABETES MELLITUS; DRUG CLEARANCE; ENZYME ACTIVITY; ENZYME MECHANISM; ENZYME REGULATION; ENZYME REPRESSION; ENZYME SPECIFICITY; GENE EXPRESSION; HAMSTER; HUMAN; HYPERGLUCAGONEMIA; HYPERGLYCEMIA; HYPERLIPIDEMIA; INFECTION; INFLAMMATION; INSULIN DEFICIENCY; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; KETOACIDOSIS; LIVER DISEASE; MALE; MODULATION; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PROTEIN EXPRESSION; RAT; SPECIES DIFFERENCE; STREPTOZOCIN DIABETES;

ANIMALS; CYTOCHROME P-450 ENZYME SYSTEM; DIABETES MELLITUS; HUMANS; INFECTION; INFLAMMATION; LIVER; OBESITY;

EID: 0034975420     PISSN: 13892002     EISSN: None     Source Type: Journal    
DOI: 10.2174/1389200013338676     Document Type: Article

References (136)